Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
HCW Biologics Inc.
Last earnings -3.4% on 2026-05-14
Revenue fell -97.9% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
HCW Biologics Inc. shows $54.2K in FY2025 revenue (-97.9% YoY), a -14677.1% net margin, and -287.9% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001828673, latest 10-Q filed 2026-05-14) · EODHD · rules-based read · as of 6/18/2026, 3:23:38 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $6.72M | $2.84M | $2.57M | $54.2K |
| Gross profit | $0.00 | $2.59M | $560K | $959K | $10.8K |
| Operating income | -$13.4M | -$15.1M | -$25.7M | -$29.5M | -$13.2M |
| Net income | -$12.9M | -$14.9M | -$25.0M | -$30.0M | -$7.96M |
| Diluted EPS | -$0.69 | -$0.42 | -$0.70 | -$30.96 | -$10.63 |
| Net margin | — | -221.7% | -879.5% | -1169.7% | -14677.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
Last 90 days: 3 open-market buys · 0 sales
| 2026-05-22 | Wong Hing C Chief Executive Officer | Buy | 114K @ $1.41 | $160K |
| 2026-05-22 | GARRETT SCOTT T Director | Buy | 178K @ $1.41 | $250K |
| 2026-05-22 | Byam Rebecca Chief Financial Officer | Buy | 14.2K @ $1.41 | $20.0K |
| 2025-05-16 | Wong Hing C Chief Executive Officer | Buy | 8.05K @ $7.45 | $60.0K |
| 2025-05-16 | Winer Gary M Director | Buy | 1.34K @ $7.45 | $10.00K |
| 2025-05-16 | GARRETT SCOTT T Director | Buy | 13.4K @ $7.45 | $100K |
| 2025-05-08 | Winer Gary M Director | Buy | 2.31K @ $26.00 | $60.0K |
| 2025-05-08 | Wong Hing C Chief Executive Officer | Buy | 92.5K @ $26.00 | $2.40M |